Chronic idiopathic axonal polyneuropathy: Comparison of patients with and without monoclonal gammopathy

Brain

Volumn 119, Issue 2, 1996, Pages 421-427

  Notermans, N C ^a,b   Wokke, J H J ^a   Van Den Berg, L H ^a   Van Der Graaf, Y ^a   Franssen, H ^a   Teunissen, L L ^a   Lokhorst, H M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Axonal; Gammopathy; Neuropathy

Indexed keywords

IMMUNOGLOBULIN M; SULFATIDE;

ADULT; ARM; ARTICLE; CHRONIC IDIOPATHIC POLYNEUROPATHY; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DENERVATION; DISABILITY; DISEASE ASSOCIATION; DISEASE SEVERITY; ELECTROMYOGRAPHY; ELECTROPHYSIOLOGY; FEMALE; HUMAN; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; NERVE BIOPSY; NERVE CONDUCTION; PATHOLOGY; POLYNEUROPATHY; PRIORITY JOURNAL;

AXONS; CHRONIC DISEASE; ELECTROPHYSIOLOGY; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; PARAPROTEINEMIAS;

EID: 0029873815     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/119.2.421     Document Type: Article

References (36)

1. Abrams GM, Latov N, Hays AP, Sherman W, Zimmerman EA. Immunocytochemical studies of human peripheral nerve with serum from patients with polyneuropathy and paraproteinemia. Neurology 1982; 32: 821-6.
2. Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). [Review]. Neurology 1991; 41: 617-18.
3. Axelsson U, Bachmann R, Hallen J. Frequency of pathological proteins (M-components) om 6,995 sera from an adult population. Acta Med Scand 1966; 179: 235-47.
4. Bleasel AF, Hawke SHB, Pollard JD, McLeod JG. IgG monoclonal paraproteinaemia and peripheral neuropathy. J Neurol Neurosurg Psychiatry 1993; 56: 52-7.
5. Gosselin S, Kyle RA, Dyck PJ. Neuropathy associated with monoclonal gammopathies of undetermined significance [see comments]. Ann Neurol 1991; 30: 54-61. Comment in: Ann Neurol 1992; 31: 689-91.
6. Gosselin S, Kyle RA, Dyck PJ. Neuropathy associated with monoclonal gammopathies of undetermined significance [see comments]. Ann Neurol 1991; 30: 54-61. Comment in: Ann Neurol 1992; 31: 689-91.
7. Harding AE, Thomas PK. The clinical features of hereditary motor and sensory neuropathy types 1 and JJ. Brain 1980; 103: 259-80.
8. Kahn SN, Riches PG, Kohn J. Paraproteinaemia in neurological disease: incidence, associations, and classification of monoclonal immunoglobulins. J Clin Pathol 1980; 33: 617-21.
9. Kaku DA, England JD, Sumner AJ. Distal accentuation of conduction slowing in polyneuropathy associated with antibodies to myelin-associated glycoprotein and sulphated glucuronyl paragloboside. Brain 1994; 117: 941-7.
10. Kyle RA, Finkelstein S, Elveback LR, Kurland LT. Incidence of monoclonal proteins in a Minnesota community with a cluster of multiple myeloma. Blood 1972; 40: 719-24.
11. Lange DJ, Trojaborg W, Latov N, Hays AP. Younger DS, Uncini A, et al. Multifocal motor neuropathy with conduction block: is it a distinct clinical entity? [see comments] Neurology 1992; 42: 497-505. Comment in: Neurology 1992; 42: 2230-1.
12. Lange DJ, Trojaborg W, Latov N, Hays AP. Younger DS, Uncini A, et al. Multifocal motor neuropathy with conduction block: is it a distinct clinical entity? [see comments] Neurology 1992; 42: 497-505. Comment in: Neurology 1992; 42: 2230-1.
13. Latov N. Antibodies to glycoconjugates in neurological disease. Clin Aspects Autoimm 1990; 4: 18-29.
14. Li F, Pestronk A, Griffin J, Feldman EL, Cornblath D, Trotter J, et al. Polyneuropathy syndromes associated with serum antibodies to sulfatide- and myelin-associated glycoprotein. Neurology 1991; 41: 357-62.
15. Mamoli A, Nemni R, Carmerlingo M, Quattrini A, Castro L, Lorenzetti I, et al. A clinical, electrophysiological, morphological and immunological study of chronic sensory neuropathy with ataxia and paraesthesia. Acta Neurol Scand 1992; 85: 110-15.
16. McLeod JG, Tuck RR, Pollard JD, Cameron J, Walsh JC. Chronic polyneuropathy of undetermined cause. J Neurol Neurosurg Psychiatry 1984; 47: 530-5.
17. Melmed C, Frail D, Duncan I, Braun P, Danoff D, Finlayson M, et al. Peripheral neuropathy with IgM kappa monoclonal imrnunoglobulin directed against myelin-associated glycoprotein. Neurology 1983; 33: 1397-405.
18. Mendell JR, Sahenk Z, Whitaker JN, Trapp BD, Yates AJ, Griggs RC, et al. Polyneuropathy and IgM monoclonal gammopathy: studies on the pathogenetic role of anti-myelin-associated glycoprotein antibody. Ann Neurol 1985; 17: 243-54.
19. Nemni R, Fazio R, Quattrini A, Lorenzetti I. Mamoli D, Canal N, et al. Antibodies to sulfatide and to chondroitin sulfate C in patients with chronic sensory neuropathy. J Neuroimmunol 1993; 43: 79-85.
20. Nobile-Orazio E, Manfredini E, Carpo M, Meucci N, Monaco S, Ferrari S, et al. Frequency and clinical correlates of anti-neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy. Ann Neurol 1994; 36: 416-24.
21. Notermans NC, Wokke JHJ, Jennekens FGI. Clinical work-up of the patient with a polyneuropathy. In: Vinken PJ, Bruyn GW, Klawans HL, editors. Handbook of Clinical Neurology, Vol. 60. Amsterdam: Elsevier, 1991: 253-70.
22. Notermans NC, Wokke JHJ, Franssen H, van der Graaf Y, Vermeulen M, van den Berg LH, et al. Chronic idiopathic polyneuropathy presenting in middle or old age. A clinical and electrophysiological study of 75 patients [see comments]. J Neurol Neurosurg Psychiatry 1993; 56: 1066-71. Comment in: J Neurol Neurosurg Psychiatry 1994; 57: 1276-7.
23. Notermans NC, Wokke JHJ, Franssen H, van der Graaf Y, Vermeulen M, van den Berg LH, et al. Chronic idiopathic polyneuropathy presenting in middle or old age. A clinical and electrophysiological study of 75 patients [see comments]. J Neurol Neurosurg Psychiatry 1993; 56: 1066-71. Comment in: J Neurol Neurosurg Psychiatry 1994; 57: 1276-7.
24. Notermans NC, Franssen H, Wieneke GH, Wokke JHJ. Temperature dependence of nerve conduction and EMG in neuropathy associated with gammopathy. Muscle Nerve 1994a; 17: 516-22.
25. Notermans NC, van Dijk GW, van der Graaf Y, van Gijn J, Wokke JHJ. Measuring ataxia: quantification based on the standard neurological examination. J Neural Neurosurg Psychiatry 1994b; 57: 22-6.
26. Notermans NC, Wokke JHJ, Lokhorst HM, Franssen H, van der Graaf Y. Jennekens FGI. Polyneuropathy associated with monoclonal gammopathy of undetermined significance. A prospective study of the prognostic value of clinical and laboratory abnormalities. Brain 1994c; 117: 1385-93.
27. Notermans NC, Wokke JHJ, van der Graaf Y, Franssen H, van Dijk GW, Jennekens FGI. Chronic idiopathic axonal polyneuropathy: a five year follow up. J Neurol Neurosurg Psychiatry 1994d; 57: 1525-7.
28. Simmons Z, Albers JW, Bromberg MB, Feldman EL. Presentation and initial clinical course in patients with chronic inflammatory demyelinating polyradiculoneuropathy: comparison of patients without and with monoclonal gammopathy. Neurology 1993; 43: 2202-9.
29. Smith IS. The natural history of chronic demyelinating neuropathy associated with benign IgM paraproteinaemia. A clinical and neurophysiological study. Brain 1994; 117: 949-57.
30. Suarez GA, Kelly JJ Jr. Polyneuropathy associated with monoclonal gammopathy of undetermined significance: further evidence that IgM-MGUS neuropathies are different than IgG-MGUS. Neurology 1993; 43: 1304-8.
31. Takatsu M, Hays AP, Latov N, Abrams GM, Nemni R, Sherman WH, et al. Immunofluorescence study of patients with neuropathy and IgM M proteins. Ann Neurol 1985; 18: 173-81.
32. Tatum AH. Experimental paraprotein neuropathy, demyelination by passive transfer of human IgM anti-myelin-associated glycoprotein. Ann Neurol 1993; 33: 502-6
33. van den Berg LH, Marrink J, de Jager AEJ, de Jong HJ, van Imhoff GW, Latov N, et al. Anti-GM1 antibodies in patients with Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 1992; 55: 8-11.
34. van den Berg LH, Lankamp CLAM, de Jager AEJ, Notermans NC, Sodaar P, Marrink J, et al. Anti-sulphatide antibodies in peripheral neuropathy. J Neurol Neurosurg Psychiatry 1993; 56: 1164-8.
35. van Swieten JC, Koudstaal PJ, Visser MC, Scheuten HJA, van Gijn J, et al. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988; 19: 604-7.
36. Yeung KB, Thomas PK, King RHM, Waddy H, Will RG, Hughes RA, et al. The clinical spectrum of peripheral neuropathies associated with benign monoclonal IgM, IgG and IgA paraproteinaemia. J Neurol 1991; 238: 383-91.